Prothena authorizes up to $100 million share repurchase plan
Source: SeekingAlpha
2026-02-27 16:24:45 ET
More on Prothena
- Prothena Corporation plc 2025 Q4 - Results - Earnings Call Presentation
- Prothena Corporation plc (PRTA) Q4 2025 Earnings Call Transcript
- Prothena Corporation plc (PRTA) Presents at Evercore 8th Annual Healthcare Conference Transcript
- Seeking Alpha’s Quant Rating on Prothena
- Historical earnings data for Prothena
Read the full article on Seeking Alpha
For further details see:
Prothena authorizes up to $100 million share repurchase plan
Prothena Corporation plc
NASDAQ: PRTA
PRTA Trading
1.92% G/L:
$10.08 Last:
347,077 Volume:
$10.21 Open:
PRTA Latest News
March 09, 2026 04:05:00 pm
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy
PRTA Stock Data
$486,084,737
38,757,587
1.22%
55
N/A
Biotechnology & Life Sciences
Healthcare
IE
Dublin 2
